Interleukin-7 and toll-like receptor 7 induce synergistic b cell and t cell activation

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Bikker, Angela ^a   Kruize, Aike A ^a   Van Der Wurff Jacobs, Kim M G ^a   Peters, Rogier P ^a   Kleinjan, Marije ^b   Redegeld, Frank ^b   De Jager, Wilco ^a   Lafeber, Floris P J G ^a   Van Roon, Joël A G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GARDIQUIMOD; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 7; KI 67 ANTIGEN; TOLL LIKE RECEPTOR 7; UNCLASSIFIED DRUG; AMINOQUINOLINE DERIVATIVE; CD19 ANTIGEN; CYTOKINE; HLA DR ANTIGEN; IMIDAZOLE DERIVATIVE;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD19+ B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOGLOBULIN PRODUCTION; MACROPHAGE; MONOCYTE; NORMAL HUMAN; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION; AGONISTS; CELL CULTURE; DRUG EFFECTS; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE;

AMINOQUINOLINES; ANTIGENS, CD19; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMIDAZOLES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-7; KI-67 ANTIGEN; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 7;

EID: 84899684675     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094756.g001     Document Type: Article

References (60)

1. Fry TJ, Mackall CL (2001) Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol 22: 564-571. (Pubitemid 33016404)
2. Kondrack RM, Harbertson J, Tan JT, McBreen ME, Surh CD, et al. (2003) Interleukin 7 regulates the survival and generation of memory CD4 cells. J Exp Med 198: 1797-1806. (Pubitemid 38032113)
3. Bikker A, Hack CE, Lafeber FP, van Roon JA (2012) Interleukin-7: a Key Mediator in T cell-driven Autoimmunity, Inflammation, and Tissue Destruction. Curr Pharm Des.
4. Mackall CL, Fry TJ, Gress RE (2011) Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 11: 330-342.
5. van Roon JA, Verweij MC, Wijk MW, Jacobs KM, Bijlsma JW, et al. (2005) Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4(+) T cells and macrophages. Arthritis Rheum 52: 1700-1710. (Pubitemid 40852878)
6. Hartgring SA, van Roon JA, Wenting-van Wijk M, Jacobs KM, Jahangier ZN, et al. (2009) Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis. Arthritis Rheum 60: 2595-2605.
7. van Roon JA, Hartgring SA, van der Wurff-Jacobs KM, Bijlsma JW, Lafeber FP (2010) Numbers of CD25+Foxp3+ T cells that lack the IL-7 receptor are increased intra-articularly and have impaired suppressive function in RA patients. Rheumatology (Oxford) 49: 2084-2089.
8. Bonifati C, Trento E, Cordiali-Fei P, Carducci M, Mussi A, et al. (1997) Increased interleukin-7 concentrations in lesional skin and in the sera of patients with plaque-type psoriasis. Clin Immunol Immunopathol 83: 41-44. (Pubitemid 27128394)
9. Rihl M, Kellner H, Kellner W, Barthel C, Yu DT, et al. (2008) Identification of interleukin-7 as a candidate disease mediator in spondylarthritis. Arthritis Rheum 58: 3430-3435.
10. Watanabe M, Ueno Y, Yajima T, Iwao Y, Tsuchiya M, et al. (1995) Interleukin is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J Clin Invest 95: 2945-2953.
11. Yamazaki M, Yajima T, Tanabe M, Fukui K, Okada E, et al. (2003) Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis. J Immunol 171: 1556-1563. (Pubitemid 36900091)
12. Rane L, Vudattu N, Bourcier K, Graniar E, Hillert J, et al. (2010) Alternative splicing of interleukin-7 (IL-7) and interleukin-7 receptor alpha (IL-7Ralpha) in peripheral blood from patients with multiple sclerosis (MS). J Neuroimmunol 222: 82-86.
13. Booth DR, Arthur AT, Teutsch SM, Bye C, Rubio J, et al. (2005) Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. J Mol Med 83: 822-830. (Pubitemid 41407866)
14. Liu X, Leung S, Wang C, Tan Z, Wang J, et al. (2010) Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat Med 16: 191-197.
15. Bikker A, Kruize AA, Wenting M, Versnel MA, Bijlsma JW, et al. (2012) Increased interleukin (IL)-7Ralpha expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity. Ann Rheum Dis.
16. Bikker A, van Woerkom JM, Kruize AA, Wenting-van Wijk M, de Jager W, et al. (2010) Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjogren's syndrome correlates with increased inflammation. Arthritis Rheum 62: 969-977.
17. Vasir B, Avigan D, Wu Z, Crawford K, Turnquist S, et al. (2005) Dendritic cells induce MUC1 expression and polarization on human T cells by an IL-7- dependent mechanism. J Immunol 174: 2376-2386. (Pubitemid 40223987)
18. Hartgring SA, Willis CR, Alcorn D, Nelson LJ, Bijlsma JW, et al. (2010) Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators. Arthritis Rheum 62: 2716-2725.
19. Watanabe M, Ueno Y, Yajima T, Okamoto S, Hayashi T, et al. (1998) Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J Exp Med 187: 389-402. (Pubitemid 28080068)
20. Watanabe M, Watanabe N, Iwao Y, Ogata H, Kanai T, et al. (1997) The serum factor from patients with ulcerative colitis that induces T cell proliferation in the mouse thymus is interleukin-7. J Clin Immunol 17: 282-292. (Pubitemid 27356133)
21. Fry TJ, Mackall CL (2005) The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 174: 6571-6576. (Pubitemid 40705615)
22. Mazzucchelli R, Durum SK (2007) Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 7: 144-154. (Pubitemid 46178275)
23. Giliani S, Mori L, de Saint Basile G, Le Deist F, Rodriguez-Perez C, et al. (2005) Interleukin-7 receptor alpha (IL-7Ralpha) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients. Immunol Rev 203: 110-126. (Pubitemid 40179697)
24. Bikker A, van der Wurff-Jacobs K, Kruize A, Peters R, Bijlsma J, et al. (2011) IL- 7-activated T-cells and monocytes drive B cell activation in patients with primary Sjögren's syndrome. Ann Rheum Dis 70: A63.
25. Sammicheli S, Ruffin N, Lantto R, Vivar N, Chiodi F, et al. (2012) IL-7 modulates B cells survival and activation by inducing BAFF and CD70 expression in T cells. J Autoimmun.
26. Radstake TR, Roelofs MF, Jenniskens YM, Oppers-Walgreen B, van Riel PL, et al. (2004) Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum 50: 3856-3865. (Pubitemid 39643932)
27. Roelofs MF, Joosten LA, Abdollahi-Roodsaz S, van Lieshout AW, Sprong T, et al. (2005) The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum 52: 2313-2322. (Pubitemid 41117415)
28. van Bon L, Cossu M, Radstake TR (2011) An update on an immune system that goes awry in systemic sclerosis. Curr Opin Rheumatol 23: 505-510.
29. Means TK, Luster AD (2005) Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus. Ann N Y Acad Sci 1062: 242-251.
30. Guerrier T, Le Pottier L, Devauchelle V, Pers JO, Jamin C, et al. (2012) Role of toll-like receptors in primary Sjogren's syndrome with a special emphasis on Bcell maturation within exocrine tissues. J Autoimmun.
31. Manoussakis MN, Spachidou MP, Maratheftis CI (2010) Salivary epithelial cells from Sjogren's syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation. J Autoimmun 35: 212-218.
32. Kawakami A, Nakashima K, Tamai M, Nakamura H, Iwanaga N, et al. (2007) Toll-like receptor in salivary glands from patients with Sjogren's syndrome: functional analysis by human salivary gland cell line. J Rheumatol 34: 1019-1026. (Pubitemid 46774848)
33. Spachidou MP, Bourazopoulou E, Maratheftis CI, Kapsogeorgou EK, Moutsopoulos HM, et al. (2007) Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjogren's syndrome. Clin Exp Immunol 147: 497-503. (Pubitemid 46208051)
34. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, et al. (2004) Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 101: 5598-5603. (Pubitemid 38481202)
35. Gilliet M, Cao W, Liu YJ (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8: 594-606.
36. Berland R, Fernandez L, Kari E, Han JH, Lomakin I, et al. (2006) Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity 25: 429-440. (Pubitemid 44376724)
37. Poole BD, Scofield RH, Harley JB, James JA (2006) Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 39: 63-70. (Pubitemid 43878521)
38. McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, et al. (2005) Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 11: 85-89. (Pubitemid 40215842)
39. Avalos AM, Busconi L, Marshak-Rothstein A (2010) Regulation of autoreactive B cell responses to endogenous TLR ligands. Autoimmunity 43: 76-83.
40. Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM (2010) Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome. J Autoimmun 34: 400-407.
41. Brkic Z, Maria NI, van Helden-Meeuwsen CG, van de Merwe JP, van Daele PL, et al. (2013) Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression. Ann Rheum Dis 72: 728-735.
42. Abe M, Goto T, Kosaka M, Wolfenbarger D, Weiss DT, et al. (1998) Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains. Clin Exp Immunol 111: 457-462. (Pubitemid 28088333)
43. Kormelink TG, Tekstra J, Thurlings RM, Boumans MH, Vos K, et al. (2010) Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity. Ann Rheum Dis 69: 2137-2144.
44. de Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, et al. (2007) Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis 66: 589-598. (Pubitemid 46707126)
45. Krenn V, Schalhorn N, Greiner A, Molitoris R, Konig A, et al. (1996) Immunohistochemical analysis of proliferating and antigen-presenting cells in rheumatoid synovial tissue. Rheumatol Int 15: 239-247. (Pubitemid 26106244)
46. Lalor PA, Mapp PI, Hall PA, Revell PA (1987) Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol Int 7: 183-186.
47. Zheng L, Zhang Z, Yu C, Yang C (2010) Expression of Toll-like receptors 7, 8, and 9 in primary Sjogren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109: 844-850.
48. Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, et al. (2005) RNAassociated autoantigens activate B cells by combined B cell antigen receptor/ Toll-like receptor 7 engagement. J Exp Med 202: 1171-1177. (Pubitemid 41586947)
49. Vanden Bush TJ, Buchta CM, Claudio J, Bishop GA (2009) Cutting Edge: Importance of IL-6 and cooperation between innate and adaptive immune receptors in cellular vaccination with B lymphocytes. J Immunol 183: 4833-4837.
50. Tsukamoto Y, Nagai Y, Kariyone A, Shibata T, Kaisho T, et al. (2009) Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production. Mol Immunol 46: 1278-1288.
51. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, et al. (2006) Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25: 417-428. (Pubitemid 44354217)
52. Barrat FJ, Meeker T, Chan JH, Guiducci C, Coffman RL (2007) Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. Eur J Immunol 37: 3582-3586.
53. Vanden Bush TJ, Bishop GA (2008) TLR7 and CD40 cooperate in IL-6 production via enhanced JNK and AP-1 activation. Eur J Immunol 38: 400-409.
54. Kattah MG, Wong MT, Yocum MD, Utz PJ (2008) Cytokines secreted in response to Toll-like receptor ligand stimulation modulate differentiation of human Th17 cells. Arthritis Rheum 58: 1619-1629. (Pubitemid 351847515)
55. Bikker A, Moret FM, Kruize AA, Bijlsma JW, Lafeber FP, et al. (2012) IL-7 drives Th1 and Th17 cytokine production in patients with primary SS despite an increase in CD4 T cells lacking the IL-7Ralpha. Rheumatology (Oxford).
56. van Roon JA, Glaudemans KA, Bijlsma JW, Lafeber FP (2003) Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis. Ann Rheum Dis 62: 113-119. (Pubitemid 36135385)
57. van Roon J, van Woerkom J, Bikker A, Wijk MWV, Bijlsma J, et al. Increased IL-7 expression in salivary glands of pSS patients correlates with immunopathology and drives TH1-associated immune responses; 2008. pp. 034.
58. Wildenberg ME, Welzen-Coppens JM, van Helden-Meeuwsen CG, Bootsma H, Vissink A, et al. (2009) Increased frequency of CD16+ monocytes and the presence of activated dendritic cells in salivary glands in primary Sjogren syndrome. Ann Rheum Dis 68: 420-426.
59. Niess JH (2008) Role of mucosal dendritic cells in inflammatory bowel disease. World J Gastroenterol 14: 5138-5148.
60. De Benedetti F, Massa M, Pignatti P, Kelley M, Faltynek CR, et al. 1995 Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis. J Rheumatol 22: 1581-1585.